There are 859 resources available
132MO - Zanidatamab (ZW25; Zani) in patients (pts) with previously treated advanced human epidermal growth factor receptor 2 (HER2)-amplified biliary tract cancer (BTC): Asia subgroup analysis of the phase IIb HERIZON-BTC-01 study
Presenter: Huichuan Sun
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Head and neck cancer
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Supportive and palliative care
Resources:
Webcast
133MO - Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966
Presenter: Richard Finn
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
394MO - Structure of QOLLTI-F in Chinese-speaking carers of palliative care patients
Presenter: Kevin Chi To Li
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
395MO - Prognostic models for survival predictions in advanced cancer patients: A systematic review and meta-analysis
Presenter: Mong Yung Fung
Session: Mini oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant 132MO and 133MO
Presenter: Angela Lamarca
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Slides
Webcast
Invited Discussant 394MO and 395MO
Presenter: Grace Yang
Session: Mini oral session: Supportive and palliative care
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session 1: Gastrointestinal tumours
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mini oral session: Supportive and palliative care
Resources:
Webcast